SEATTLE--(BUSINESS WIRE)--Sonoma Biotherapeutics ... The Center will be located on the Seattle waterfront at 501 Elliott Avenue West, a property owned by Office Properties Income Trust and ...

Claire Page, a senior associate scientist in process development, working in a fume hood at Sonoma Biotherapeutics recently ... the floors of the building on Elliott Avenue, which will bring ...

Unison is uniquely situated on Elliott Bay with unobstructed ... has signed a 10-year lease in the 501 building for more than 83,000 square feet. Sonoma Biotherapeutics occupies three floors ...

Regulatory T cell-focused Sonoma Biotherapeutics has been following a slow and steady path ever since bringing in a whopping $265 million in a 2021 fundraising round, one of the largest of the year.

SOUTH SAN FRANCISCO, Calif. & SEATTLE, May 13, 2025--(BUSINESS WIRE)--Sonoma Biotherapeutics, Inc., a clinical-stage biotechnology company developing engineered regulatory T cell (Treg ...

SOUTH SAN FRANCISCO, Calif. & SEATTLE--(BUSINESS WIRE)--Sonoma Biotherapeutics, Inc., a clinical-stage biotechnology company developing engineered regulatory T cell (T reg) therapies for ...

Sonoma Biotherapeutics, Inc., a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies for autoimmune and inflammatory diseases, today announced the ...